We are live on ! Find out more
WP

Waycross Partners Portfolio holdings

AUM $1.05B
1-Year Est. Return 20.92%
This Fund
S&P 500
This Quarter Est. Return
+3.22%
1 Year Est. Return
+20.92%
3 Year Est. Return
+78.91%
5 Year Est. Return
+114.23%
10 Year Est. Return
–
AUM
$723M
AUM Growth
+$71.6M
Cap. Flow
+$55.5M
Cap. Flow %
7.68%
Top 10 Hldgs %
48.37%
Holding
74
New
3
Increased
27
Reduced
3
Closed
9

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$18M
2
ADBE icon
Adobe
ADBE
+$17.3M
3
DG icon
Dollar General
DG
+$16.5M
4
CSX icon
CSX Corp
CSX
+$9.13M
5
HON icon
Honeywell
HON
+$5.27M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$13.8M
2
DLTR icon
Dollar Tree
DLTR
+$12.4M
3
NSC icon
Norfolk Southern
NSC
+$12M
4
CVS icon
CVS Health
CVS
+$5.94M
5
SYK icon
Stryker
SYK
+$2.38M

Sector Composition

Rank Sector Weight
1 Technology 28.94%
2 Healthcare 16.42%
3 Financials 13.93%
4 Consumer Discretionary 11.37%
5 Communication Services 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LMT icon
51
Lockheed Martin
LMT
$134B
$848K 0.12%
1,450
– –
MCD icon
52
McDonald's
MCD
$197B
$785K 0.11%
2,578
– –
PEP icon
53
PepsiCo
PEP
$195B
$754K 0.1%
4,433
– –
PG icon
54
Procter & Gamble
PG
$353B
$746K 0.1%
4,309
– –
AMGN icon
55
Amgen
AMGN
$212B
$725K 0.1%
2,250
– –
CL icon
56
Colgate-Palmolive
CL
$75.2B
$623K 0.09%
6,000
– –
DE icon
57
Deere & Co
DE
$172B
$575K 0.08%
1,379
– –
NKE icon
58
Nike
NKE
$64.1B
$548K 0.08%
6,200
– –
ABT icon
59
Abbott
ABT
$188B
$489K 0.07%
4,289
– –
RTX icon
60
RTX Corp
RTX
$293B
$382K 0.05%
3,151
– –
WMT icon
61
Walmart Inc
WMT
$908B
$323K 0.04%
4,000
– –
JNJ icon
62
Johnson & Johnson
JNJ
$649B
$276K 0.04%
1,700
– –
AVGO icon
63
Broadcom
AVGO
$1.83T
$259K 0.04%
1,500
– –
XOM icon
64
ExxonMobil
XOM
$634B
$245K 0.03%
2,090
– –
BMY icon
65
Bristol-Myers Squibb
BMY
$130B
$236K 0.03%
+4,557
New +$214K
ALGN icon
66
Align Technology
ALGN
$12.6B
– –
-8,000
Closed -$1.93M
DLTR icon
67
Dollar Tree
DLTR
$24.5B
– –
-116,544
Closed -$12.4M
HSIC icon
68
Henry Schein
HSIC
$9.7B
– –
-30,000
Closed -$1.92M
LVS icon
69
Las Vegas Sands
LVS
$32B
– –
-40,000
Closed -$1.77M
MTD icon
70
Mettler-Toledo International
MTD
$27.9B
– –
-1,000
Closed -$1.4M
NSC icon
71
Norfolk Southern
NSC
$77.5B
– –
-55,904
Closed -$12M
SCHW
72
Charles Schwab
SCHW
$184B
– –
-25,000
Closed -$1.84M
SYK icon
73
Stryker
SYK
$133B
– –
-7,000
Closed -$2.38M
TMO icon
74
Thermo Fisher Scientific
TMO
$214B
– –
-25,014
Closed -$13.8M
1 2
3

Similar funds

LPC
Long Pond Capital New York $1.05B AUM 16.49% 1-Year Est. Return
HWCM
Hudson Way Capital Management Dallas, Texas $1.05B AUM 6.84% 1-Year Est. Return
AA
Apriem Advisors Irvine, California $1.05B AUM 22.09% 1-Year Est. Return
CIA
CCM Investment Advisers Columbia, South Carolina $1.04B AUM 40.82% 1-Year Est. Return
CIA
Compass Ion Advisors Conshohocken, Pennsylvania $1.05B AUM 16.28% 1-Year Est. Return
SPC
Spirepoint Private Client Vero Beach, Florida $1.05B AUM 22.43% 1-Year Est. Return
LAM
L2 Asset Management Wayland, Massachusetts $1.05B AUM 29.07% 1-Year Est. Return
CA
Continuum Advisory Eagle, Idaho $1.04B AUM 21.13% 1-Year Est. Return

Waycross Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Waycross Partners held 74 positions worth $723M, up 11% from $652M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Waycross Partners deployed $55.5M of net new capital in Q3 2024, opening 3 new positions and adding to 27 existing holdings. Its largest new stake was Becton Dickinson: 76,961 shares worth $18.6M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was CVS Health, an estimated $5.94M trimmed.

  • Waycross Partners's largest Q3 2024 buy was Becton Dickinson: 76,961 shares worth $18.6M.
  • Waycross Partners added most to Dollar General in Q3 2024, an estimated $16.5M increase.
  • Waycross Partners's biggest Q3 2024 reduction was CVS Health, cutting an estimated $5.94M.
  • Waycross Partners fully exited Thermo Fisher Scientific in Q3 2024, selling an estimated $13.8M.
  • Waycross Partners's ten largest holdings make up 48% of its $723M portfolio in Q3 2024.
  • Waycross Partners opened 3 new positions and closed 9 in Q3 2024.
  • Waycross Partners's portfolio value rose 11% quarter-over-quarter to $723M.

Based on Waycross Partners's 13F filing for Q3 2024, filed 8 Nov 2024.